Champions Oncology (CSBR) Reports Q3 Loss of $0.21/Share
Tweet
Share
E-mailGet Alerts CSBR Hot Sheet
Price: $4.96 -4.25%
Financial Fact:
General and administrative: 1.53M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
General and administrative: 1.53M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Champions Oncology (NASDAQ: CSBR) reported Q3 EPS of ($0.21), versus ($0.49) reported last year. Revenue for the quarter came in at $2.6 million, versus $1.8 million reported last year.
For earnings history and earnings-related data on Champions Oncology (CSBR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
- Vireo Growth completes acquisition of C21 Investments
- BMO starts chip stocks coverage: Here are its preferred picks
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
